Predicting Residual Neck Disease in Patients With Oropharyngeal Squamous Cell Carcinoma Treated With Radiation Therapy (original) (raw)
Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab
Jordi Giralt
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015
View PDFchevron_right
Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy
Willa Shi
International journal of radiation oncology, biology, physics, 2012
View PDFchevron_right
Unilateral radiotherapy treatment for p16/human papillomavirus-positive squamous cell carcinoma of unknown primary in the head and neck
Alan Herschtal
The Laryngoscope, 2018
View PDFchevron_right
De-escalation of radiation dose for human papillomavirus-positive oropharyngeal head and neck squamous cell carcinoma: A�case report and preclinical and clinical literature review
Jordan Schecter
Oncology Letters, 2015
View PDFchevron_right
Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma
Phuc Nguyen-tan, Quynh-thu Le
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014
View PDFchevron_right
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
Jordi Giralt
European journal of cancer (Oxford, England : 1990), 2016
View PDFchevron_right
Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality
Markus Wolfensberger
International Journal of Cancer, 2009
View PDFchevron_right
Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy
Jonathan Clark
British Journal of Cancer, 2010
View PDFchevron_right
Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
Quynh-thu Le
Journal of Clinical Oncology, 2010
View PDFchevron_right
The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: Evaluation of the randomised DAHANCA 6&7 trial
Lena Specht
Radiotherapy and Oncology, 2011
View PDFchevron_right
Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status
Mathew Meeneghan, Paul Read
Cancer, 2010
View PDFchevron_right
Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma
Jose Zevallos
Journal of Clinical Oncology, 2019
View PDFchevron_right
Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns
tzu-chen yen
PloS one, 2017
View PDFchevron_right
Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
J. Alsner
Journal of Clinical Oncology, 2009
View PDFchevron_right
What are the implications of human papillomavirus status in oropharyngeal tumors for clinical practice?
Jan Klozar, R. Tachezy
Current opinion in otolaryngology & head and neck surgery, 2014
View PDFchevron_right
Extracapsular extension of neck nodes and absence of human papillomavirus 16‐DNA are predictors of impaired survival in p16‐positive oropharyngeal squamous cell carcinoma
Gunnar Wichmann
Cancer
View PDFchevron_right
Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer
Jens Overgaard
Radiotherapy and Oncology, 2014
View PDFchevron_right
Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status
Linda Marklund
Cancers
View PDFchevron_right
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
Johanna Sjövall
Radiation Oncology
View PDFchevron_right
Changing trends in the management of the neck in oropharyngeal squamous cell carcinoma
Hesham Mohamed
Head & neck, 2017
View PDFchevron_right
Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection
AKIRA GANAHA
European Archives of Oto-Rhino-Laryngology, 2018
View PDFchevron_right
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
susanto saint
View PDFchevron_right
Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma
Eric Moore
The Laryngoscope, 2016
View PDFchevron_right
Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma
Mark Weissler
Cancer, 2018
View PDFchevron_right
Low‐risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: Equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone
Jose Zevallos
Head & Neck
View PDFchevron_right
High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma
marco alessandro pierotti
Journal of Clinical Oncology, 2006
View PDFchevron_right
Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor
Avraham Eisbruch
Head & Neck, 2014
View PDFchevron_right